Join our community of traders FOR FREE!

  • Learn
  • Improve yourself
  • Get Rewards
Learn More

herbalife_logoHerbalife, the nutrition selling company under attack from shortseller Bill Ackman, allowed an affiliated business to continue operating in its network for almost a decade after Canadian authorities had labelled the operation a pyramid scheme, a Financial Times investigation indicates.

Mr Ackman, founder of hedge fund Pershing Square, stated earlier that Herbalife itself is a pyramid scheme, while the company has said it is legitimate, prompting a high-profile battle between investors on either side of the argument.

The history of a company called Online Business Systems, which until this year specialized in recruiting salesmen for the Herbalife network, raises questions about the practices Herbalife had previously tolerated.

OBS is the successor to Global Online Systems, a company judged to be a criminal “scheme of pyramid selling” by a Canadian federal court in 2004. Both were part of an ecosystem of business built around promoting Herbalife to sell marketing materials and other services such as “sales leads” to the direct seller’s recruits.

Online check in archives show that websites operated by GOS such as www.4u4meletsdream.com, were rebranded as OBS. A website that encouraged GOS participants to register with OBS by September said that they would remain in the network: “Your Herbalife lineage remains the same regardless of the changes to your new marketing system.”

Those recruited by OBS became part of Mr and Mrs Dahl’s network of Herbalife salespeople, and by 2009 the couple were ranked in the company’s top 50 distributors, joining its “Chairman’s Club”. Ms Stoltz and Ms Thom also continued to be prominent Herbalife distributors.

Earlier this year, Herbalife took steps to distance itself from OBS by restricting distributors use of leads and marketing materials provided by the company. Following that change, Mr Dahl moved to a rival direct seller. Herbalife has since banned the sale of leads to or by distributors entirely. OBS, Mr and Mrs Dahl, Ms Stoltz and Ms Thom did not respond to requests from Financial Times for a comment on the topic.

TradingPedia.com is a financial media specialized in providing daily news and education covering Forex, equities and commodities. Our academies for traders cover Forex, Price Action and Social Trading.

Related News

  • British pound retreated against strong US dollarBritish pound retreated against strong US dollar On Wednesday the sterling tumbled against the US dollar, as strong support was provided for the greenback after a series of economic data from the United States gave a breath of optimism for economy.GBP/USD took a gradual slide to hit a […]
  • Natural gas futures weekly recap, November 24 – November 28Natural gas futures weekly recap, November 24 – November 28 Natural gas fell further on Friday, marking a sizable weekly decline, as forecasts for mild weather across most of the US in early-December offset bullish US inventory data.On the New York Mercantile Exchange, natural gas for delivery in […]
  • Kiwi advances after RBNZ hold, hits key resistanceKiwi advances after RBNZ hold, hits key resistance Key Moments NZD/USD trades near 0.5820 in the Asian session after the RBNZ leaves the OCR at 2.25% for a second straight meeting. Price action turns cautiously bullish as the pair holds above 0.5790 but remains capped below the […]
  • JPMorgan share price down, fourth-quarter performance hit by legal costsJPMorgan share price down, fourth-quarter performance hit by legal costs JPMorgan Chase & Co announced on Wednesday a decline in earnings due to a drop in revenue from fixed-income trading and higher than expected legal costs.Net income decreased to $4.9 billion during the fourth quarter from $5.3 billion a […]
  • Oppenheimer Asset Management rates UnitedHealth as “Buy”Oppenheimer Asset Management rates UnitedHealth as “Buy” Oppenheimer Asset Management has a bullish view on UnitedHealth Group Inc (NYSE: UNH) shares, as it pointed out the company “exhibits the strongest trend in the managed care sub-industry.”Oppenheimer has assigned a “Buy” rating on the […]
  • Sarepta Therapeutics closes on $600M credit facilitySarepta Therapeutics closes on $600M credit facility Sarepta Therapeutics Inc (NASDAQ: SRPT) said on Friday that it had closed on a $600 million senior secured revolving credit facility with a bank syndicate.JPMorgan Chase Bank N.A. serves as Administrative Agent and acted as Lead Arranger […]